LeMaitre Vascular Inc
NASDAQ:LMAT

Watchlist Manager
LeMaitre Vascular Inc Logo
LeMaitre Vascular Inc
NASDAQ:LMAT
Watchlist
Price: 105.425 USD -1.55%
Market Cap: 2.4B USD
Have any thoughts about
LeMaitre Vascular Inc?
Write Note

LeMaitre Vascular Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

LeMaitre Vascular Inc
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
LeMaitre Vascular Inc
NASDAQ:LMAT
Additional Paid In Capital
$210.7m
CAGR 3-Years
6%
CAGR 5-Years
15%
CAGR 10-Years
11%
Becton Dickinson and Co
NYSE:BDX
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Additional Paid In Capital
$21B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
2%
Stryker Corp
NYSE:SYK
Additional Paid In Capital
$2.4B
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
7%
Abbott Laboratories
NYSE:ABT
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Intuitive Surgical Inc
NASDAQ:ISRG
Additional Paid In Capital
$9.4B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
13%
No Stocks Found

LeMaitre Vascular Inc
Glance View

Market Cap
2.4B USD
Industry
Health Care

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company is headquartered in Burlington, Massachusetts and currently employs 450 full-time employees. The company went IPO on 2006-10-19. The firm develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. The company sold its principal product in the United States, Europe, the United Kingdom, Canada and Asia Pacific. The firm sales its products and services primarily through a direct sales force. Its products and services offering includes Allografts, Angioscopes, Balloon Catheters for Embolectomy and Thrombectomy, Balloon Catheters for Occlusion and Perfusion, Bovine Grafts, Vascular and Cardiac Patches, Carotid Shunts, Closure Systems, Ovine Vascular Grafts, Polyester Vascular Grafts, ePTFE Vascular Grafts, Radiopaque Tape, and Valvulotomes.

LMAT Intrinsic Value
54.085 USD
Overvaluation 49%
Intrinsic Value
Price

See Also

What is LeMaitre Vascular Inc's Additional Paid In Capital?
Additional Paid In Capital
210.7m USD

Based on the financial report for Sep 30, 2024, LeMaitre Vascular Inc's Additional Paid In Capital amounts to 210.7m USD.

What is LeMaitre Vascular Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
11%

Over the last year, the Additional Paid In Capital growth was 6%. The average annual Additional Paid In Capital growth rates for LeMaitre Vascular Inc have been 6% over the past three years , 15% over the past five years , and 11% over the past ten years .

Back to Top